封面
市场调查报告书
商品编码
1696250

全球 Omega-3 市场 - 2025 至 2032 年

Global Omega-3 Market - 2025-2032

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球 Omega-3 市场规模达到 26.4 亿美元,预计到 2032 年将达到 48.5 亿美元,在 2025-2032 年预测期内的复合年增长率为 7.92%。

市场扩张是由于人类饮食中越来越多地使用 omega-3 成分来增强大脑和心臟健康。此外,预计医疗保健和个人健康方面的消费者支出增加将推动产品需求。随着消费者寻求传统鱼油的替代品,市场不断实现产品来源多样化。磷虾油是最广泛使用的 Omega-3 来源之一,因为与普通鱼油相比,它具有更优良的品质。

此外,Aker Biomarine Antarctic AS 等重要企业正致力于透过引进新的捕捞船来增加其产品供应,以提高产能,该公司 2021 年的收入就是明证。发展中国家的政府正在推出多项措施来鼓励南极磷虾捕捞,包括提供研究资金和组成创新联盟,这可能会刺激产业成长。预计这些变数将在预测期内推动产品需求。

动态的

Omega-3 的健康益处日益增加

人类饮食中需要含有 Omega-3 脂肪酸,尤其是 EPA 和 DHA,以确保适当的生长、发育和健康。它们有益于心臟健康、关节和发炎缓解、眼睛健康、认知功能、怀孕和儿童发育以及免疫功能。众所周知,Omega-3 脂肪酸可以降低心血管疾病的风险。近年来,全球心血管疾病死亡率呈上升趋势。在西撒哈拉以南非洲和南亚,心血管疾病发生率上升。根据联合国人口基金会(印度)的数据,到 2050 年,印度老年人罹患心臟病的数量预计将达到 1,910 万人。

印度和中国等国家心臟病发病率不断上升,对心臟保健产品的需求不断增加,从而促进了 omega-3 产品市场的发展。 Omega-3 脂肪酸还可以帮助预防和治疗多种眼部问题,包括干眼症。根据研究,摄取 omega-3 脂肪酸(无论是透过膳食或补充剂)都可能降低黄斑部病变和青光眼的几率。因此,预计 omega-3 对人类健康不同方面的益处将推动其市场需求。

供应链约束和永续性挑战

全球 Omega-3 市场的主要限制因素之一是由于过度捕捞和环境法规导致的鱼油原料稀缺。大部分 omega-3 产品来自海洋资源,包括鳀鱼、沙丁鱼和鲭鱼,这些资源受季节变化、地缘政治限制和永续性需求的影响。

例如,2023年,全球最大的凤尾鱼油生产国秘鲁因鱼类数量减少而实施捕捞禁令,导致 Omega-3 市场供应短缺和价格不稳定。因此,製造商现在正在寻找替代来源,例如藻类衍生的 omega-3,儘管这些来源仍然更昂贵且需要更高的可扩展性才能满足不断增长的全球需求。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动态

  • 影响因素
    • 驱动程式
      • Omega-3 的健康益处日益增加
    • 限制
      • 供应链约束和永续性挑战
    • 机会
    • 影响分析

第五章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 可持续性分析
  • DMI 意见

第 6 章:按来源

  • 藻类
  • 磷虾
  • 其他的

第 7 章:按类型

  • 二十二碳六烯酸 (DHA)
  • 二十碳五烯酸 (EPA)
  • 亚麻油酸 (ALA)
  • 其他的

第 8 章:按应用

  • 功能性食品和饮料
    • 植物油
    • 乳木果油
  • 膳食补充剂
  • 婴儿配方奶粉
  • 化妆品
  • 动物营养
  • 其他的

第九章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章:公司简介

  • Polaris
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
  • Koninklijke DSM NV
  • BASF SE
  • Corbion NV
  • ADM
  • Simris Alg AB
  • Croda International Plc
  • Novotech Nutraceuticals, Inc.
  • Source Omega LLC
  • Algarithm

第 12 章:附录

简介目录
Product Code: FB9407

Global Omega-3 Market reached US$ 2.64 billion in 2024 and is expected to reach US$ 4.85 billion by 2032, growing with a CAGR of 7.92% during the forecast period 2025-2032.

The market expansion is due to the increasing use of omega-3 ingredients in the human diet to enhance brain and heart health. Furthermore, rising consumer spending in healthcare and personal well-being is predicted to drive product demand. The market is constantly diversifying its product sources as consumers seek alternatives to traditional fish oil. Krill oil is one of the most extensively used sources of omega-3 because of its superior qualities when compared to regular fish oil.

Furthermore, significant enterprises like as Aker Biomarine Antarctic AS are working on boosting capacity by introducing new catching vessels to increase their product offerings, as evidenced by the company's revenues in 2021. Governments in developing countries are launching a number of initiatives to encourage Antarctic Krill fishing, including providing research money and forming innovative alliances, which could spur industry growth. Such variables are expected to drive the product demand during the forecast period.

Dynamic

Rising Health Benefits of Omega-3

Omega-3s, notably EPA and DHA, are required in the human diet for appropriate growth, development and health. They are beneficial for heart health, joint and inflammation relief, eye health, cognitive function, pregnancy and child development and immune function. Omega-3 fatty acids are recognized to lessen the risk of cardiovascular disease. Cardiovascular disease mortality has recently been on the rise around the world. In Western Sub-Saharan Africa and South Asia, cardiovascular disease rates have risen. According to the United Nations Population Fund (India), the number of instances of heart disease among older adults in India is anticipated to be 19.1 million by 2050.

Countries such as India and China, where the prevalence of heart disease is expanding, create demand for heart health goods, bolstering the omega-3 product market. Omega-3 fatty acids can also help prevent and treat several eye problems, including dry eye syndrome. According to studies, ingesting omega-3 fatty acids, whether in meals or supplements, may lower your chance of getting macular degeneration and glaucoma. As a result, omega-3's benefits in different aspects of human health are projected to boost its market demand.

Supply Chain Constraints and Sustainability Challenges

One of the primary constraints in the global omega-3 market is the scarcity of fish oil-based raw materials due to overfishing issues and environmental regulations. The majority of omega-3 production comes from marine sources including anchovies, sardines and mackerel, which are subject to seasonal changes, geopolitical constraints and sustainability demands.

For example, in 2023, Peru, the world's top producer of anchovy-based fish oil, implemented fishing prohibitions owing to diminishing fish populations, resulting in supply shortages and price instability in the omega-3 market. As a result, manufacturers are now searching for alternate sources like algae-derived omega-3, although these are still more expensive and require more scalability to satisfy expanding worldwide demand.

Segment Analysis

The global omega-3 market is segmented based on source, type, application and region.

DHA in the global market is expected to drive the market.

In 2024, the DHA segment accounted for the largest percentage of global omega-3 market. The segment's growth is due to the increasing use of the product in newborn formulae to improve an infant's overall health. DHA is the most vital and plentiful omega-3 fatty acid in the human diet, contributing to overall body health. DHA is essential for the development and maturation of an infant's brain and vision.

Furthermore, it is commonly utilized in dietary supplements and fortified foods. It is used to treat dementia, ADHD, CAD and type 2 diabetes. Companies create new items to fulfill market demand. For example, in 2022 orlo Nutrition launched a DHA Starter Kit with an algal omega-3 supplement to assist the brain, heart, joints and body systems.

Geographical Penetration

Growing Health Consciousness in Asia-Pacific.

Asia-Pacific is expected to be the fastest growing region in the global omega-3 market. Several reasons fueling the region's growth include expanding consumer health consciousness, an aging population valuing cognitive health and high birth rates, which increase demand for infant nutritional products. Additionally, the popularity of plant-based diets has resulted in an increase in demand for algae-based omega-3 supplements.

Furthermore, other significant players have innovated, such as Daewoong Bio, which developed CRA-TG in June 2024, a combination of the hyperlipidemia medicine rosuvastatin and omega-3 intended at lowering patients' triglyceride levels. This new addition to Daewoong Bio's hyperlipidemia treatment range joins nine other medications, including Atorvastatin Tablets and Oma-TG Soft Capsule. CRA-TG has exhibited better lipid profiles and increased tolerance and stability.

Competitive Landscape

The major global players in the market include Polaris, Koninklijke DSM N.V., BASF SE, Corbion NV, ADM, Simris Alg AB, Croda International Plc, Novotech Nutraceuticals, Inc., Source Omega LLC and Algarithm.

Key Developments

  • In January 2024, Ritual introduced the Omega-3 DHA + EPA supplement. It contains 500 mg of omega-3 fatty acids in a 2:1 ratio of DHA and EPA. The oil is sustainably sourced from microalgae in La Foret-Fouesnant, France and processed using unique technique to minimize oxidation, resulting in minimal burp-back.
  • In March 2023, Epax announced a $40 million investment in molecular distillation technology to enhance the processing of highly concentrated omega 3.
  • In May 2023, Nuseed Global will launch Nuseed Nutriterra, an omega-3-enriched plant-based oil designed for the human nutrition and dietary supplement industries.

Why Choose DataM?

  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than Source generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Health Benefits of Omega-3
    • 4.1.2. Restraints
      • 4.1.2.1. Supply Chain Constraints and Sustainability Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Sustainable Analysis
  • 5.6. DMI Opinion

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Algae*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Fish
  • 6.4. Krill
  • 6.5. Others

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Docosahexaenoic Acid (DHA)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Eicosapentaenoic Acid (EPA)
  • 7.4. Alpha-Linolenic Acid (ALA)
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Functional Foods and Beverage*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Vegetable Oil
    • 8.2.4. Shea Butter
  • 8.3. Dietary Supplements
  • 8.4. Infant Formula
  • 8.5. Cosmetics
  • 8.6. Animal Nutrition
  • 8.7. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Polaris*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Koninklijke DSM N.V.
  • 11.3. BASF SE
  • 11.4. Corbion NV
  • 11.5. ADM
  • 11.6. Simris Alg AB
  • 11.7. Croda International Plc
  • 11.8. Novotech Nutraceuticals, Inc.
  • 11.9. Source Omega LLC
  • 11.10. Algarithm

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us